Leukemia | Tumor

Knocking Out Chronic Myeloid Leukemia with Precision

February 22nd 2021, 2:00pm


Patients with chronic myeloid leukemia are living longer, some even stopping treatment, thanks to a plethora of targeted therapies.

A ‘T-ALL’ Order: Treating T-Cell Acute Lymphoblastic Leukemia

February 19th 2021, 8:00pm


Oncologists and researchers are racing to identify new therapies to help better treat a rare form of acute lymphoblastic leukemia.

Keep it Flowing: Combating COVID-19 Blood Shortages in Cancer Treatment

February 12th 2021, 1:00pm


Blood shortages during the COVID-19 pandemic have forced cancer centers to get creative to ensure patients with hematologic malignancies are able to get transfusions in a timely manner.

FDA Grants Investigational Therapy Breakthrough Designation for Chronic Myeloid Leukemia

February 10th 2021, 10:00pm


The Food and Drug Administration has granted the investigational therapy asciminib a breakthrough therapy designation for the treatment of certain adults with Philadelphia chromosome-positive chronic myeloid leukemia. The designation may allow for expedited review of the drug.

Friday Frontline: Leukemia Survivor Organizes Essential Blood Drives During Pandemic, A Kindergarten Teacher Teaches Her Students During Chemo Sessions Through Zoom, And More

January 8th 2021, 4:00pm


From one leukemia survivor organizing essential blood drives for patients with cancer as COVID-19 delays hit, to a kindergarten teacher handling a recurrence of ovarian cancer by continuing to teach her students through Zoom, here’s what’s happening in the cancer landscape this week.

FDA Approves Iclusig for Adult Patients with Resistant/Intolerant Chronic-Phase CML

December 19th 2020, 12:25am


The Food and Drug Administration approved the supplemental new drug application for Iclusig (ponatinib) to treat patients with chronic-phase chronic myeloid leukemia (CML) with resistance or intolerance to at least two prior kinase inhibitors.

Faith, Science, and Miracles: A Conversation About CAR-T Cell Therapy with the Whitehead Family

December 4th 2020, 8:00pm


Emily Whitehead was the first child to receive chimeric antigen receptor (CAR)-T cell therapy. Eight years later, she and her parents discuss her ongoing remission from acute lymphoblastic leukemia.

Friday Frontline: Preliminary Evidence Shows Connection Between Cancer Recurrence and Stress-Related Hormones, Texas Mayor Tests Positive for COVID-19 After Cancer Diagnosis, and More

December 4th 2020, 4:00pm


From a recently published study showing preliminary connections between elevated levels of stress-related hormones and cancer recurrence, to a Texas mayor receiving a diagnosis of cancer and COVID-19, here’s what’s happening in the cancer landscape this week.

Cancer May Not Suggest Poor Health Outcomes After COVID-19, Study Shows

November 16th 2020, 4:00pm


A retrospective study of patients with COVID-19 showed that those with cancer were not more likely to experience severe symptoms or death due to the virus than those without cancer. Rather, only age and obesity were associated with poor COVID-19 outcomes.

Friday Frontline: A Father Receiving Treatment for Leukemia Surprises His Daughter on Her Wedding Day; ‘The Wanted’ Singer Tom Parker Diagnosed with Inoperable Brain Tumor; and More

October 16th 2020, 3:00pm


From “The Wanted” singer Tom Parker announcing he has been diagnosed with stage 4 glioblastoma and is undergoing treatment, to a Houston-area father receiving treatment for leukemia surprising his daughter on her wedding day, here’s what’s happening in the cancer landscape this week.